Open source drug discovery in practice: a case study.

by Christine Årdal, John-Arne Røttingen
Published 2012-01-01

An open source business model for malaria.

by Christine Årdal, John-Arne Røttingen
Published 2015-01-01

Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development

by Ursula Theuretzbacher, Christine Årdal, Stephan Harbarth
Published 2017-03-01

Industrial perceptions of medicines regulatory harmonization in the East African Community.

by Live Storehagen Dansie, Walter Denis Odoch, Christine Årdal
Published 2019-01-01

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

by Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi, John-Arne Røttingen
Published 2018-04-01

Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature rev...

by Yohann Lacotte, Christine Årdal, Marie-Cécile Ploy, on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI)
Published 2020-08-01

The effect of generic market entry on antibiotic prescriptions in the United States

by Cecilia Kållberg, Jemma Hudson, Hege Salvesen Blix, Christine Årdal, Eili Klein, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen, Ramanan Laxminarayan
Published 2021-05-01

National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation

by Christine Årdal, Yohann Lacotte, Suzanne Edwards, Marie-Cécile Ploy, on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI)
Published 2021-06-01

Introduction and geographic availability of new antibiotics approved between 1999 and 2014.

by Cecilia Kållberg, Christine Årdal, Hege Salvesen Blix, Eili Klein, Elena M Martinez, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen, Ramanan Laxminarayan
Published 2018-01-01

A one health framework to estimate the cost of antimicrobial resistance

by Chantal M. Morel, Richard A. Alm, Christine Årdal, Alessandra Bandera, Giacomo M. Bruno, Elena Carrara, Giorgio L. Colombo, Marlieke E. A. de Kraker, Sabiha Essack, Isabel Frost, Bruno Gonzalez-Zorn, Herman Goossens, Luca Guardabassi, Stephan Harbarth, Peter S. Jørgensen, Souha S. Kanj, Tomislav Kostyanev, Ramanan Laxminarayan, Finola Leonard, Gabriel Levy Hara, Marc Mendelson, Malgorzata Mikulska, Nico T. Mutters, Kevin Outterson, Jesus Rodriguez Baňo, Evelina Tacconelli, Luigia Scudeller, the GAP-ON€ network
Published 2020-11-01